Literature DB >> 11070177

Human placental transport of vinblastine, vincristine, digoxin and progesterone: contribution of P-glycoprotein.

F Ushigome1, H Takanaga, H Matsuo, S Yanai, K Tsukimori, H Nakano, T Uchiumi, T Nakamura, M Kuwano, H Ohtani, Y Sawada.   

Abstract

To elucidate the role of P-glycoprotein in human placenta, we examined its expression in placenta, and the transcellular transport and uptake of P-glycoprotein substrates in cultured human placental choriocarcinoma epithelial cells (BeWo cells). The uptake of [(3)H]vinblastine and [(3)H]vincristine into BeWo cells was increased in the presence of a metabolic inhibitor, sodium azide. The basolateral-to-apical transcellular transport of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin was greater than the apical-to-basolateral transcellular transport. In the presence of cyclosporin A, the basolateral-to-apical transcellular transport of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin was significantly increased, and the apical-to-basolateral transcellular transport was decreased. The uptake of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin into BeWo cells was significantly enhanced in the presence of several inhibitors, such as verapamil or mouse monoclonal antibody anti-P-glycoprotein MX-MDR (MRK16) as well as cyclosporin A. Although progesterone significantly enhanced the uptake of [(3)H]vinblastine, [(3)H]vincristine and [(3)H]digoxin into BeWo cells, the uptake of [(3)H]progesterone was not affected by these inhibitors. Immunoblot analysis revealed that P-glycoprotein with a molecular weight of 172 kDa was expressed in BeWo cells and isolated trophoblast cells. Furthermore, P-glycoprotein was detected in human placental brush-border membrane vesicles, but not in human placental basolateral membrane vesicles. In conclusion, these data suggest that P-glycoprotein is expressed on the brush-border membrane (maternal side) of human placental trophoblast cells. P-Glycoprotein is considered to regulate the transfer of several substances including vinblastine, vincristine and digoxin from mother to fetus, and to protect the fetus from toxic substances.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11070177     DOI: 10.1016/s0014-2999(00)00743-3

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  25 in total

1.  Cardamonin, a natural chalcone, reduces 5-fluorouracil resistance of gastric cancer cells through targeting Wnt/β-catenin signal pathway.

Authors:  Gaochao Hou; Xiang Yuan; Yi Li; Gaoyu Hou; Xianli Liu
Journal:  Invest New Drugs       Date:  2019-05-17       Impact factor: 3.850

Review 2.  Role of P-glycoprotein in pharmacokinetics: clinical implications.

Authors:  Jiunn H Lin; Masayo Yamazaki
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

3.  Placenta-on-a-chip: a novel platform to study the biology of the human placenta.

Authors:  Ji Soo Lee; Roberto Romero; Yu Mi Han; Hee Chan Kim; Chong Jai Kim; Joon-Seok Hong; Dongeun Huh
Journal:  J Matern Fetal Neonatal Med       Date:  2015-06-15

4.  Transport characteristics of L-carnosine and the anticancer derivative 4-toluenesulfonylureido-carnosine in a human epithelial cell line.

Authors:  Carsten Uhd Nielsen; Claudiu T Supuran; Andrea Scozzafava; Sven Frokjaer; Bente Steffansen; Birger Brodin
Journal:  Pharm Res       Date:  2002-09       Impact factor: 4.200

5.  Differential bidirectional transfer of indinavir in the isolated perfused human placenta.

Authors:  Sreeja Sudhakaran; Hany Ghabrial; Roger L Nation; David C M Kong; Neil M Gude; Peter W Angus; Craig R Rayner
Journal:  Antimicrob Agents Chemother       Date:  2005-03       Impact factor: 5.191

Review 6.  Overcoming transporter-mediated multidrug resistance in cancer: failures and achievements of the last decades.

Authors:  Miglė Paškevičiūtė; Vilma Petrikaitė
Journal:  Drug Deliv Transl Res       Date:  2019-02       Impact factor: 4.617

7.  Proton gradient-dependent transport of valproic acid in human placental brush-border membrane vesicles.

Authors:  Hiroaki Nakamura; Fumihiko Ushigome; Noriko Koyabu; Shoji Satoh; Kiyomi Tsukimori; Hitoo Nakano; Hisakazu Ohtani; Yasufumi Sawada
Journal:  Pharm Res       Date:  2002-02       Impact factor: 4.200

Review 8.  Maternal-fetal transport of hypoglycaemic drugs.

Authors:  Facundo Garcia-Bournissen; Denice S Feig; Gideon Koren
Journal:  Clin Pharmacokinet       Date:  2003       Impact factor: 6.447

9.  Transport of digoxin-loaded polymeric nanoparticles across BeWo cells, an in vitro model of human placental trophoblast.

Authors:  Norah A Albekairi; Sanaalarab Al-Enazy; Shariq Ali; Erik Rytting
Journal:  Ther Deliv       Date:  2015

10.  Functional role of p-glycoprotein and binding protein effect on the placental transfer of lopinavir/ritonavir in the ex vivo human perfusion model.

Authors:  Pierre-Francois Ceccaldi; Laurent Gavard; Laurent Mandelbrot; Elisabeth Rey; Robert Farinotti; Jean-Marc Treluyer; Sophie Gil
Journal:  Obstet Gynecol Int       Date:  2009-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.